Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NiproTSE:8086 +0.39%70 Gross Margin % is 32.89% as of Mar. 2026, which is 8% above its 10-year median of 30.41. GuruFocus rates TSE:8086 with a GF Score™ of 70/100 and a GF Value™ of 円1,457.04 (Fairly Valued). The stock has 6 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Nipro ranks worse than 79.43% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Nipro's Gross Profit for the
three
months ended in Mar. 2026 was 円56,981 Mil. Nipro's Revenue for the
three
months ended in Mar. 2026 was 円173,233 Mil. Therefore, Nipro's Gross Margin % for the quarter that ended in Mar. 2026 was 32.89%.
The historical rank and industry rank for Nipro's Gross Margin % or its related term are showing as below:
TSE:8086'
s Gross Margin % Range Over the Past 10 Years
Min: 29.2 Med: 30.41 Max: 32.15
Current: 31.53
During the past 13 years, the highestGross Margin % of Nipro was 32.15%. The lowest was 29.20%. And the median was 30.41%.
TSE:8086's Gross Margin % is ranked worse than 79.43% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs TSE:8086: 31.53
Nipro had a gross margin of 32.89% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Nipro was 0.30% per year.
Nipro (TSE:8086) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Nipro had a gross margin of 32.89% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Nipro Gross Margin % Related Terms
Nipro Gross Margin % Historical Data
* Premium members only.
The historical data trend for Nipro's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:8086 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Nipro's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Nipro's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Nipro (TSE:8086) has a Gross Margin % of 32.89% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Nipro and its competitors. This is near median its historical median of 30.41. Over the past decade, Nipro's Gross Margin % has ranged from 29.20 to 32.15. According to the industry distribution chart, Nipro ranks #641 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 79.4%.
Is Nipro's Gross Margin % too high?
Nipro's current Gross Margin % of 32.89% is near median its 10-year median of 30.41. Over the past 10 years, this metric has ranged from a low of 29.20 to a high of 32.15. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Nipro's value of 32.89% is 36.8% below this industry median. Based on the distribution chart, Nipro ranks #641 out of 807 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nipro has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nipro ranks #641 out of 807 companies for Gross Margin %. This places Nipro in the lower half of its industry. The industry median Gross Margin % is 52.03. Nipro's value of 32.89% is 36.8% below this benchmark. Historically, Nipro's own Gross Margin % has ranged from 29.20 to 32.15 over the past decade. While the company's 10-year median is 30.41 vs. the industry median of 52.03, Nipro has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nipro's current Gross Margin % of 32.89% is 36.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Nipro and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nipro's current Gross Margin % is 32.89%, which is near median its own 10-year median of 30.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Fairly Valued. The stock's GF Value™ is 円1,457.04, compared to a current price of 円1,552.50 — trading 6.6% above its estimated fair value. The current Gross Margin % is 32.89%, which is near median its 10-year median of 30.41 and 36.8% below the Medical Devices & Instruments industry median of 52.03. Nipro's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Nipro (TSE:8086), the current Gross Margin % is 32.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nipro (TSE:8086) Overvalued in 2026?
Based on GuruFocus' analysis, Nipro stock appears to be overvalued.
The current stock price of 円1,552.50 is trading 6.6% above its estimated GF Value™ of 円1,457.04.
GuruFocus considers Nipro to be Fairly Valued.
Key valuation signals for TSE:8086:
Gross Margin %: 32.89% (near median its 10-year median of 30.41)
GF Value™: 円1,457.04 vs. price of 円1,552.50 (6.6% above fair value)
Industry Position: 36.8% below the Medical Devices & Instruments median (#641 of 807)
No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
70GF Score
Get the complete analysis for TSE:8086
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:8086 has been successfully added to your 
